A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (CCS1477-04)

Principal Investigator

Dr Sarah Gooding

Contact us

Email: Latephasehaematology@ouh.nhs.uk

IRAS number

1012518